PriceTargets.com logo

Tactile Systems Technology - TCMD Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $23.00
  • Forecasted Upside: 35.29%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 1 Strong Buy Ratings
$17.00 As of 12/20/2024 06:40 PM ET
▲ +0.05 (0.29%)

This chart shows the closing price for TCMD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Tactile Systems Technology Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TCMD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TCMD

Analyst Price Target is $23.00
▲ +35.29% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Tactile Systems Technology in the last 3 months. The average price target is $23.00, with a high forecast of $23.00 and a low forecast of $23.00. The average price target represents a 35.29% upside from the last price of $17.00.

This chart shows the closing price for TCMD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 3 polled investment analysts is to moderate buy stock in Tactile Systems Technology. This rating has held steady since October 2024, when it changed from a Strong Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/30/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/28/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/27/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/22/2024
  • 1 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
11/21/2024
  • 1 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/21/2024

Latest Recommendations

  • 1 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/5/2024OppenheimerDowngradeOutperform ➝ Market Perform
11/5/2024BTIG ResearchDowngradeBuy ➝ Neutral
9/26/2024B. RileyInitiated CoverageBuy$23.00
9/25/2024B. RileyUpgradeStrong-Buy
8/8/2023OppenheimerBoost TargetOutperform ➝ Outperform$24.00 ➝ $30.00
5/9/2023OppenheimerBoost Target$18.00 ➝ $24.00
5/9/2023Piper SandlerBoost Target$25.00 ➝ $30.00
4/17/2023BTIG ResearchBoost TargetBuy$27.00 ➝ $28.00
8/2/2022OppenheimerLower TargetOutperform$35.00 ➝ $18.00
8/2/2022Piper SandlerLower TargetOverweight$28.00 ➝ $25.00
7/18/2022BTIG ResearchLower TargetBuy$29.00 ➝ $27.00
2/23/2022BTIG ResearchLower Target$44.00 ➝ $29.00
2/23/2022Piper SandlerLower Target$40.00 ➝ $28.00
1/3/2022Piper SandlerLower Target$45.00 ➝ $40.00
11/9/2021OppenheimerLower TargetOutperform ➝ Outperform$62.00 ➝ $45.00
11/9/2021Piper SandlerLower TargetOverweight$70.00 ➝ $45.00
11/9/2021BTIG ResearchBoost TargetNeutral ➝ Buy$44.00 ➝ $70.00
1/25/2021BTIG ResearchBoost TargetAverage ➝ In-Line$51.00 ➝ $60.00
11/13/2020OppenheimerUpgradeMarket Perform ➝ Outperform$55.00
8/3/2020OppenheimerInitiated CoverageHold
5/4/2020OppenheimerInitiated CoverageHold
4/23/2020BTIG ResearchReiterated RatingBuy
4/7/2020BTIG ResearchLower TargetBuy$72.00 ➝ $63.00
4/6/2020Piper SandlerReiterated RatingBuy$70.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

0.33 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 8 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2024
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 3 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 7 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 9 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 5 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024
  • 2 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 2 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Tactile Systems Technology logo
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Read More

Today's Range

Now: $17.00
Low: $16.82
High: $17.65

50 Day Range

MA: $16.32
Low: $13.43
High: $19.54

52 Week Range

Now: $17.00
Low: $11.12
High: $21.10

Volume

359,413 shs

Average Volume

258,835 shs

Market Capitalization

$407.95 million

P/E Ratio

26.15

Dividend Yield

N/A

Beta

1.2

Frequently Asked Questions

What sell-side analysts currently cover shares of Tactile Systems Technology?

The following Wall Street sell-side analysts have issued reports on Tactile Systems Technology in the last year: B. Riley, BTIG Research, Oppenheimer Holdings Inc., and StockNews.com.
View the latest analyst ratings for TCMD.

What is the current price target for Tactile Systems Technology?

0 Wall Street analysts have set twelve-month price targets for Tactile Systems Technology in the last year. Their average twelve-month price target is $23.00, suggesting a possible upside of 35.3%. B. Riley has the highest price target set, predicting TCMD will reach $23.00 in the next twelve months. B. Riley has the lowest price target set, forecasting a price of $23.00 for Tactile Systems Technology in the next year.
View the latest price targets for TCMD.

What is the current consensus analyst rating for Tactile Systems Technology?

Tactile Systems Technology currently has 2 hold ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for TCMD.

What other companies compete with Tactile Systems Technology?

Other companies that are similar to Tactile Systems Technology include RxSight, InMode, MiMedx Group, Establishment Labs and BioLife Solutions. Learn More about companies similar to Tactile Systems Technology.

How do I contact Tactile Systems Technology's investor relations team?

Tactile Systems Technology's physical mailing address is 3701 Wayzata Blvd Suite 300, MINNEAPOLIS MN, 55413. The company's listed phone number is (612) 355-5100 and its investor relations email address is [email protected]. The official website for Tactile Systems Technology is www.tactilemedical.com. Learn More about contacing Tactile Systems Technology investor relations.